» Articles » PMID: 27301868

Prenatal Exposure to the Organophosphate Insecticide Chlorpyrifos Enhances Brain Oxidative Stress and Prostaglandin E2 Synthesis in a Mouse Model of Idiopathic Autism

Overview
Publisher Biomed Central
Date 2016 Jun 16
PMID 27301868
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Autism spectrum disorders (ASD) are emerging as polygenic and multifactorial disorders in which complex interactions between defective genes and early exposure to environmental stressors impact on the correct neurodevelopment and brain processes. Organophosphate insecticides, among which chlorpyrifos (CPF), are widely diffused environmental toxicants associated with neurobehavioral deficits and increased risk of ASD occurrence in children. Oxidative stress and dysregulated immune responses are implicated in both organophosphate neurodevelopmental effects and ASD etiopathogenesis. BTBR T+tf/J mice, a well-studied model of idiopathic autism, show several behavioral and immunological alterations found in ASD children, and we recently showed that CPF gestational exposure strengthened some of these autistic-like traits. In the present study, we aimed at investigating whether the behavioral effects of gestational CPF administration are associated with brain increased oxidative stress and altered lipid mediator profile.

Methods: Brain levels of F2-isoprostanes (15-F2t-IsoP), as index of in vivo oxidative stress, and prostaglandin E2 (PGE2), a major arachidonic acid metabolite released by immune cells and by specific glutamatergic neuron populations mainly in cortex and hippocampus, were assessed by specific enzyme-immuno assays in brain homogenates from BTBR T+tf/J and C57Bl6/J mice, exposed during gestation to either vehicle or CPF. Measures were performed in mice of both sexes, at different postnatal stages (PNDs 1, 21, and 70).

Results: At birth, BTBR T+tf/J mice exhibited higher baseline 15-F2t-IsoP levels as compared to C57Bl6/J mice, suggestive of greater oxidative stress processes. Gestational treatment with CPF-enhanced 15-F2t-IsoP and PGE2 levels in strain- and age-dependent manner, with 15-F2t-IsoP increased in BTBR T+tf/J mice at PNDs 1 and 21, and PGE2 elevated in BTBR T+tf/J mice at PNDs 21 and 70. At PND 21, CPF effects were sex-dependent being the increase of the two metabolites mainly associated with male mice. CPF treatment also induced a reduction of somatic growth, which reached statistical significance at PND 21.

Conclusions: These findings indicate that the autistic-like BTBR T+tf/J strain is highly vulnerable to environmental stressors during gestational period. The results further support the hypothesis that oxidative stress might be the link between environmental neurotoxicants such as CPF and ASD. The increased levels of oxidative stress during early postnatal life could result in delayed and long-lasting alterations in specific pathways relevant to ASD, of which PGE2 signaling represents an important one.

Citing Articles

Prostaglandins: Biological Action, Therapeutic Aspects, and Pathophysiology of Autism Spectrum Disorders.

Yui K, Imataka G, Ichihashi M Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996792 PMC: 11854465. DOI: 10.3390/cimb47020071.


A critical period for paired-housing-dependent autistic-like behaviors attenuation in a prenatal valproic acid-induced male mouse model of autism.

Yang J, Yin B, Yang C, Jiang M, Li Z Front Neurosci. 2025; 18:1467047.

PMID: 39897951 PMC: 11782243. DOI: 10.3389/fnins.2024.1467047.


Rodent Models for ASD Biomarker Development.

Lee H, Sahin M Adv Neurobiol. 2024; 40:189-218.

PMID: 39562446 DOI: 10.1007/978-3-031-69491-2_8.


Central Causation of Autism/ASDs via Excessive [Ca]i Impacting Six Mechanisms Controlling Synaptogenesis during the Perinatal Period: The Role of Electromagnetic Fields and Chemicals and the NO/ONOO(-) Cycle, as Well as Specific Mutations.

Pall M Brain Sci. 2024; 14(5).

PMID: 38790433 PMC: 11119459. DOI: 10.3390/brainsci14050454.


The association between prenatal oxidative stress levels measured by isoprostanes and offspring neurodevelopmental outcomes at 36 months.

Carey M, Kivumbi A, Rando J, Mesaros A, Melnyk S, James S Brain Behav Immun Health. 2024; 38:100775.

PMID: 38706573 PMC: 11067487. DOI: 10.1016/j.bbih.2024.100775.


References
1.
Terry Jr A . Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms. Pharmacol Ther. 2012; 134(3):355-65. PMC: 3366364. DOI: 10.1016/j.pharmthera.2012.03.001. View

2.
Roberts 2nd L, Fessel J, Davies S . The biochemistry of the isoprostane, neuroprostane, and isofuran Pathways of lipid peroxidation. Brain Pathol. 2005; 15(2):143-8. PMC: 8095955. DOI: 10.1111/j.1750-3639.2005.tb00511.x. View

3.
Careaga M, Schwartzer J, Ashwood P . Inflammatory profiles in the BTBR mouse: how relevant are they to autism spectrum disorders?. Brain Behav Immun. 2014; 43:11-6. PMC: 4776653. DOI: 10.1016/j.bbi.2014.06.006. View

4.
Andersen S . Trajectories of brain development: point of vulnerability or window of opportunity?. Neurosci Biobehav Rev. 2003; 27(1-2):3-18. DOI: 10.1016/s0149-7634(03)00005-8. View

5.
Chauhan A, Chauhan V, Brown W, Cohen I . Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. Life Sci. 2004; 75(21):2539-49. DOI: 10.1016/j.lfs.2004.04.038. View